Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells-Reference-Cited by-同舟云学术

Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells

Published:2016-02-22 Issue:11 Volume:7 Page:11756-11769
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Hasegawa Masanori¹,Takahashi Hidekazu¹²,Rajabi Hasan¹,Alam Maroof¹,Suzuki Yozo¹³,Yin Li¹,Tagde Ashujit¹,Maeda Takahiro¹,Hiraki Masayuki¹,Sukhatme Vikas P.⁴,Kufe Donald¹

Affiliation:

1. Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

2. Department of Gastrointestinal Surgery, Graduate School of Medicine, Osaka University, Suita City, Osaka, Japan

3. Department of Gastroenterological Surgery, Osaka Police Hospital, Osaka City, Osaka, Japan

4. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of ferroptosis strategy to overcome tumor therapy resistance in breast and different cancer cells;IRAN J BASIC MED SCI;2024

2. Integrated Single-cell and Bulk RNA Sequencing Analysis Cross Talk between Ferroptosis-related Genes and Prognosis in Oral Cavity Squamous Cell Carcinoma;Recent Patents on Anti-Cancer Drug Discovery;2024-08

3. The Role of Methylation in Ferroptosis;Journal of Cardiovascular Translational Research;2024-07-29

4. Diagnostic and predictive significance of the ferroptosis-related gene TXNIP in lung adenocarcinoma stem cells based on multi-omics;Translational Oncology;2024-07

5. Ferroptosis is an effective strategy for cancer therapy;Medical Oncology;2024-04-23